Sixmo

Medicinal product

(Invented) name

Sixmo

Active substance (s)

Buprenorfinas

Strength

74,2 mg

Pharmaceutical form

implantas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07BC01, Buprenorphine

Marketing authorisation holder

L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A, Italija

Date of authorisation

2019-06-20

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

Yes

Controlled substance type

Narkotinis

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Implant	1 vnt.
Buprenorfinas	74,2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102009	88111	1088111	paketėlis	4 implantai ir aplikatorius N1		Receptinis	EU/1/19/1369/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-08-01	Išregistruotas
2019-06-20	Registruotas